Skip to main content
NRGene Technologies Ltd. logo

NRGene Technologies Ltd. — Investor Relations & Filings

Ticker · NRGN ISIN · IL0011720716 TA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 24 across all filing types
Latest filing 2022-04-03 Earnings Release
Country IL Israel
Listing TA NRGN

About NRGene Technologies Ltd.

https://nrgene.com/

NRGene Technologies Ltd. is a genomics company that develops and commercializes artificial intelligence-based software solutions for the agricultural and food-tech sectors. The company's platform utilizes advanced algorithms to analyze large-scale genomic data, significantly accelerating and optimizing the natural breeding of plants and animals. By decoding genetic information, NRGene enables breeding companies and researchers to identify and select for beneficial traits, such as increased yield, improved quality, and enhanced resilience to environmental stressors. This technology aims to support the development of more productive and sustainable agricultural practices to address global food security challenges.

Recent filings

Filing Released Lang Actions
Quarterly analysis update report, target price remains 30.9NIS
Earnings Release Classification · 1% confidence The document text is heavily garbled (likely due to encoding issues, indicated by '����'), but key structural elements suggest it is a formal filing or announcement. I can identify dates (03/04/2022, 12/12/2021, 31/10/2021) and references to financial periods ('Q4_Update_Report_Eng_isa.pdf'). Crucially, the text contains a reference to a specific attached file: '�� ���� �� ���� ������: ����� ����� ������: ���� ����� ���� �� ���� ������: | �����: ��� ��� 1 , ������ 4672519 �����: 09-9502888 ���: 09-9502888 ���� ��������: [email protected] 1 |'. More importantly, near the end, there is a line: '��"� ����� �������: *030422_NRGene_Q4_Update_Report_Eng_isa.pdf*'. The presence of a specific report filename, combined with the short document length (3027 chars), strongly suggests this document is an announcement *about* a report rather than the report itself. This aligns with the definition of a Report Publication Announcement (RPA). It is not a full 10-K, IR, or ER, as it seems to be a cover sheet or notification. Q4 2021
2022-04-03 Russian
Quarterly analysis update report, target price remains 30.9NIS
Investor Presentation Classification · 1% confidence The document is titled "INDEPENDENT EQUITY RESEARCH - UPDATE REPORT 12.12.21" for NRGENE TECHNOLOGIES LTD. It contains detailed analysis of the company's Q3 2021 events, investment thesis, market analysis (bioinformatics, seed, genotyping), and concludes with a specific stock price target valuation (NIS 29.4 to NIS 32.4). This structure—independent analysis, market context, and valuation—is characteristic of an Equity Research or Investor Presentation report, rather than an official regulatory filing (like 10-K, ER, or IR). Since 'Investor Presentation' (IP) covers detailed presentations for investors focusing on financials, strategy, and market position, and this document fits that description perfectly (it's an update report with valuation), IP is the most appropriate classification. It is not a formal company filing like an ER or 10-K.
2021-12-12 English
Quarterly analysis update report, target price remains 30.9NIS
Environmental & Social Information Classification · 1% confidence The document text is highly fragmented and contains non-standard characters, suggesting it might be a poorly parsed or metadata-heavy document. However, key elements point towards a specific type of announcement. I see references to a date (12/12/2021), a company name (implied by context, possibly related to 'NRGene'), and crucially, a reference to an attached PDF file: '121221_NRGene_Update_Report-Eng-vFinal_isa.pdf'. The presence of a specific report filename and the short nature of the text (2862 chars) strongly suggest this is not the full report itself (like 10-K or IR), but rather an announcement that a report has been published or is available. This aligns best with the Report Publication Announcement (RPA) definition, which covers announcements regarding the release or publication of company reports.
2021-12-12 Russian
INITIAL ANALSIS FROST & SULLIVAN, stock price target NIS 30.9
Investor Presentation Classification · 1% confidence The document is titled "INDEPENDENT EQUITY RESEARCH" and contains detailed analysis, market benchmarking, valuation summaries (including price targets like NIS 29.4 to NIS 32.4), investment theses, and descriptions of the company's technology and financials. This structure is characteristic of a detailed research report prepared by an external analyst firm (Frost & Sullivan in this case) covering a publicly traded company (NRGene Technologies Ltd). This type of document is not a mandatory regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an in-depth analysis document intended for investors. Among the provided codes, 'IP' (Investor Presentation) is the closest fit for detailed, non-regulatory analytical material, although this is technically an 'Equity Research Report'. Given the options, 'IP' often encompasses detailed analytical documents shared with investors, or 'IR' (Interim Report) if it were a comprehensive financial review, but the focus here is clearly on external valuation and investment thesis rather than a formal financial statement filing. Since it is a detailed analysis/presentation of investment rationale, 'IP' (Investor Presentation) is the most appropriate classification for this type of external, forward-looking analysis document, even though it is explicitly labeled as 'Equity Research'. It is not a standard regulatory filing, nor is it a short announcement (RPA).
2021-10-31 English
INITIAL ANALSIS FROST & SULLIVAN, stock price target NIS 30.9
Regulatory Filings Classification · 1% confidence The document text is highly fragmented and contains non-standard characters, suggesting it might be a poorly rendered or partial filing, possibly related to a regulatory submission or a report announcement. Key indicators are the presence of dates (31/10/2021, 2021-05-16), references to 'FROST & SULLIVAN RESEARCH & CONSULTING LTD', and a file name reference: '311021_NRGene_Report_NRGene_isa.pdf'. The structure includes fields for company identification, dates, and a section that seems to be a cover page or metadata for a report. Crucially, the document length is very short (2746 chars) and it references a specific report file ('Report_NRGene_isa.pdf'). This strongly suggests it is an announcement about the publication of a report rather than the full report itself (like an Annual Report or Interim Report). Given the context of regulatory filings and the announcement nature, the most appropriate general category is 'Regulatory Filings' (RNS), as it doesn't clearly map to a specific financial report type (10-K, IR, ER) or a specific corporate action (DIV, CAP, MANG). If the underlying report was known to be an earnings release, ER would be considered, but based only on this text, RNS is the safest fallback for an announcement of a published document.
2021-10-31 Russian
Changes in company's and securities names effective of May 13, 2021
Regulatory Filings
2021-05-12 Hebrew (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.